Diabetes Technology and Therapeutics : Impact Factor & More
eISSN: 1557-8593pISSN: 1520-9156
Share this on:
Key Metrics
CiteScore 
10.3
Eigenfactor
0.005 - 0.01
H-Index
97
Impact Factor
5 - 10
SJR
Q1Endocrinology
SNIP
1.97
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Diabetes Technology and Therapeutics
Diabetes Technology and Therapeutics Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Diabetes Technology and Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Diabetes Technology and Therapeutics
Erratum to: "HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis".
- 28 Jun 2026
- Diabetes technology & therapeutics
Settings Associated with Optimal Glycemic Outcomes with the Omnipod® 5 Automated Insulin Delivery System: Evidence from Real-World Users with Type 1 Diabetes.
- 24 Jun 2026
- Diabetes technology & therapeutics
Automated Insulin Delivery Systems in Hospitals: A Systematic Review with Meta-Analysis.
- 24 Jun 2026
- Diabetes technology & therapeutics
Predicting Risk for Diabetic Ketoacidosis in Children Recently Diagnosed with Type 1 Diabetes Using the Risk Index for Diabetic Ketoacidosis.
- 23 Jun 2026
- Diabetes technology & therapeutics
Percent Time Below Range Is Strongly Associated with Clinically Important Level 2 Hypoglycemia Events in Individuals with Type 1 Diabetes.
- 23 Jun 2026
- Diabetes technology & therapeutics
Association Between Longitudinal Time in Range and Albuminuria in Insulin-Treated Diabetes.
- 23 Jun 2026
- Diabetes technology & therapeutics
Erratum to: "HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis".
- 28 Jun 2026
- Diabetes technology & therapeutics
Settings Associated with Optimal Glycemic Outcomes with the Omnipod® 5 Automated Insulin Delivery System: Evidence from Real-World Users with Type 1 Diabetes.
- 24 Jun 2026
- Diabetes technology & therapeutics
Automated Insulin Delivery Systems in Hospitals: A Systematic Review with Meta-Analysis.
- 24 Jun 2026
- Diabetes technology & therapeutics
Predicting Risk for Diabetic Ketoacidosis in Children Recently Diagnosed with Type 1 Diabetes Using the Risk Index for Diabetic Ketoacidosis.
- 23 Jun 2026
- Diabetes technology & therapeutics
Percent Time Below Range Is Strongly Associated with Clinically Important Level 2 Hypoglycemia Events in Individuals with Type 1 Diabetes.
- 23 Jun 2026
- Diabetes technology & therapeutics
Association Between Longitudinal Time in Range and Albuminuria in Insulin-Treated Diabetes.
- 23 Jun 2026
- Diabetes technology & therapeutics
FAQs on Diabetes Technology and Therapeutics
How long has Diabetes Technology and Therapeutics been actively publishing? 
What is the publishing frequency of Diabetes Technology and Therapeutics?
How many articles did Diabetes Technology and Therapeutics publish last year?
What is the eISSN & pISSN for Diabetes Technology and Therapeutics?
What is Citescore for Diabetes Technology and Therapeutics?
What is the H Index for Diabetes Technology and Therapeutics ?
What is SNIP score for Diabetes Technology and Therapeutics?
What is the SJR for Diabetes Technology and Therapeutics?
Who is the publisher of Diabetes Technology and Therapeutics?
